Go Pro

UiPath (NYSE:PATH) Releases Quarterly Earnings Results, Misses Expectations By $0.06 EPS

UiPath logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • UiPath reported quarterly EPS of $0.09, missing analysts’ consensus estimate of $0.15 by $0.06. The company posted a 19.58% net margin and 7.92% return on equity.
  • Shares rose to $18.09, near the company’s 12-month high of $19.84, with trading volume above average. UiPath has a market capitalization of approximately $9.37 billion.
  • Analysts maintain a consensus “Hold” rating with an average price target of $14.80, while CEO Daniel Dines sold roughly $22.5 million worth of shares. Institutional investors own 62.50% of the stock.
  • Five stocks we like better than UiPath.

UiPath (NYSE:PATH - Get Free Report) released its earnings results on Thursday. The company reported $0.09 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.15 by ($0.06), Zacks reports. UiPath had a net margin of 19.58% and a return on equity of 7.92%.

UiPath Stock Performance

NYSE PATH traded up $0.10 on Thursday, hitting $18.09. 56,810,070 shares of the stock traded hands, compared to its average volume of 46,072,090. The business's fifty day moving average is $13.66 and its two-hundred day moving average is $11.87. UiPath has a 12 month low of $9.20 and a 12 month high of $19.84. The firm has a market capitalization of $9.37 billion, a price-to-earnings ratio of 30.15, a PEG ratio of 2.17 and a beta of 1.02.

Insider Buying and Selling at UiPath

In other news, CEO Daniel Dines sold 1,402,347 shares of the stock in a transaction on Wednesday, August 19th. The stock was sold at an average price of $16.07, for a total transaction of $22,535,716.29. Following the completion of the transaction, the chief executive officer owned 26,491,238 shares in the company, valued at approximately $425,714,194.66. This represents a 5.03% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 22.44% of the company's stock.

Institutional Investors Weigh In On UiPath

Institutional investors have recently added to or reduced their stakes in the business. State Street Corp boosted its position in UiPath by 66.4% during the fourth quarter. State Street Corp now owns 13,004,786 shares of the company's stock worth $213,148,000 after purchasing an additional 5,189,438 shares during the period. AQR Capital Management LLC lifted its stake in shares of UiPath by 76.0% during the 2nd quarter. AQR Capital Management LLC now owns 11,407,569 shares of the company's stock valued at $145,732,000 after buying an additional 4,926,341 shares in the last quarter. Morgan Stanley boosted its holdings in UiPath by 54.0% in the 4th quarter. Morgan Stanley now owns 9,310,304 shares of the company's stock worth $152,596,000 after buying an additional 3,262,930 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in UiPath by 8.5% in the 3rd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 6,710,035 shares of the company's stock worth $89,761,000 after buying an additional 526,416 shares during the period. Finally, Dimensional Fund Advisors LP grew its stake in UiPath by 13.4% in the 3rd quarter. Dimensional Fund Advisors LP now owns 5,505,064 shares of the company's stock valued at $73,627,000 after buying an additional 648,624 shares in the last quarter. 62.50% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

PATH has been the topic of several research reports. Bank of America upped their price objective on shares of UiPath from $12.00 to $13.00 and gave the company an "underperform" rating in a report on Friday, May 29th. BMO Capital Markets dropped their price target on UiPath from $14.00 to $13.00 and set a "market perform" rating on the stock in a research note on Monday, June 1st. UBS Group raised their price objective on UiPath from $12.00 to $19.00 and gave the company a "neutral" rating in a research note on Monday. DA Davidson cut their target price on UiPath from $13.00 to $12.00 and set a "neutral" rating on the stock in a report on Friday, May 29th. Finally, Royal Bank Of Canada lifted their price target on shares of UiPath from $12.00 to $15.00 and gave the company a "sector perform" rating in a research report on Friday, August 14th. Two research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $14.80.

Check Out Our Latest Research Report on PATH

UiPath Company Profile

(Get Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.

Featured Articles

Earnings History for UiPath (NYSE:PATH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in UiPath Right Now?

Before you consider UiPath, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.

While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines